Optimization of Small Molecule Drugs Binding to Highly Polar Target Sites: Lessons from the Discovery and Development of Neuraminidase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|6|5|423-434

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.5, 2006-03, pp. : 423-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of Highly Potent Small Molecule Kallikrein Inhibitors

By  

Medicinal Chemistry, Vol. 2, Iss. 6, 2006-11 ,pp. : 545-553

Bentham Science Publishers

Access to resources Recommend Favorite

Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates

By  

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-12 ,pp. : 4374-4404

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition

By Backes AC   Zech B   Felber B   Klebl B   Müller G  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 12, 2008-12 ,pp. : 1409-1425

Informa Healthcare

Access to resources Recommend Favorite

Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1818-1826

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Small Molecule Inhibitors for Prevention of Complement- Mediated Immune Hemolysis

By  

Drug Design Reviews - Online, Vol. 2, Iss. 2, 2005-03 ,pp. : 137-143

Bentham Science Publishers

Access to resources Recommend Favorite